Es-2（人卵巢透明細(xì)胞癌細(xì)胞）
CBP60293
詢 價
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| I. General information | |
| Synonyms: | Es-2 |
| Background: | The ES-2 cell line was established from a surgical tumor specimen taken from a 47 year old black woman. |
| Species: | Homo sapiens, human |
| Tissue: | ovary |
| Disease: | clear cell carcinoma |
| Gender: | female, 47 years, Black |
| Morphology: | fibroblast |
| Growth Mode: | adherent |
| Doubling Time: | 24 hrs |
| DNA Profile: | Amelogenin: X CSF1PO: 10,15 D13S317: 11 D16S539: 11,13 D5S818: 11,13 D7S820: 11 THO1: 9.3 TPOX: 8,12 vWA: 16,17 Our Cell Line Authentication Service |
| Culture Medium: |
RPMI-1640+10%FBS Es-2完全培養(yǎng)基，# CBP60293M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Genes Expressed: | P glycoprotein |
| Cellular Products: | P glycoprotein |
| Tumor Formation: | Yes, tumors developed within 21 days at 100% frequency (5/5) in nude mice inoculated subcutaneously with 107 cells. |
| Comments: | The tumor was described as a poorly differentiated ovarian clear cell carcinoma. Initially, the cells were grown in soft agar. The cells exhibit low to moderate resistance to a number of chemotherapeutic agents including doxorubicin, cisplatin, carmustine, etoposide and cyanomorpholinodoxorubicin (MRA-CN). ES-2 cells express low levels of P glycoprotein For more information, please contact us (4008-750-250). |
